Of all the hepatitis viruses, D is the most poorly known. This small virus, which can only infect people already infected with Hepatitis B, has so far been little studied. Hepatitis D is one of the most dangerous forms ...
May 19, 2020
0
0
A simple saliva test developed by QUT biomedical scientists has detected early throat cancer in a person who had no symptom and no clinical signs of cancer.
May 12, 2020
0
112
A research team led by Hong Kong Baptist University (HKBU) has developed a novel anti-Epstein-Barr virus (EBV) drug that can selectively disrupt a viral protein produced by EBV, leading to the shrinkage of tumors caused by ...
May 11, 2020
0
8
Cancer of the esophagus is a leading cause of cancer-related mortality worldwide. Altered dietary intakes of certain nutrients have been associated with cancer risk.
May 8, 2020
0
14
In what is believed to be a first-of-its-kind study to evaluate the safety of a type of immunotherapy before surgery in patients with an aggressive form of skin cancer, researchers report that the treatment eliminated pathologic ...
Apr 27, 2020
0
10
Putting together research for publication can be a challenging and time-consuming process, heightened even further because of the current COVID-19 situation, during which non-essential labs have been hibernated and many researchers ...
Apr 20, 2020
0
2
An active immune system plays an important role in stopping cancer progression by identifying tumor cells and targeting them for destruction. Any deviation in the normal activities of the immune system could lead to accelerated ...
Apr 14, 2020
0
264
A new study identifies some of the most critical genes that may drive a rare but deadly liver cancer, providing a road map for developing drugs that target those genes.
Apr 14, 2020
0
99
New findings from researchers at The University of Texas MD Anderson Cancer Center about how some cancer cells become "addicted" to glucose could open up fresh approaches to therapy strategies for cancers with high levels ...
Mar 30, 2020
0
90
(HealthDay)—For patients with locally advanced upper tract urothelial carcinoma (UTUC), gemcitabine-platinum combination chemotherapy improves disease-free survival, according to a study published online March 5 in The ...
Mar 17, 2020
0
0
